Behavioral sensitivity to amphetamine or scopolamine after acute administration of nicotine in the rat

International Journal of Occupational Medicine and Environmental Health

Volumn 18, Issue 1, 2005, Pages 71-81

  Gralewicz, Sławomir ^a   Lutz, Piotr ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Amphetamine; Behavioral sensitization; Nicotine; Open field; Rat; Scopolamine

Indexed keywords

ACETYLCHOLINESTERASE; AMPHETAMINE; CLOFENVINFOS; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; ORGANOPHOSPHATE INSECTICIDE; ORGANOPHOSPHORUS COMPOUND; OXOTREMORINE; PHYSOSTIGMINE; SCOPOLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC STIMULATION; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; LOCOMOTION; MALE; NONHUMAN; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

EID: 18344370969     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ecobichon DJ. Organophosphorus ester insecticides. In: Ecobichon DJ, Joy RM, editors. Pesticides and Neurological Diseases. Boca Raton, FL: CRC Press; 1994. p: 171-249.
2. Feldman RG, editor. Occupational and environmental neurotoxicology. In: Organophosphorus Compounds. New York: Lippincott-Raven; 1999. p. 421-41.
3. Duffy FH, Burchfiel JL, Bartels PH, Gaon M, Sim VM. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol 1979;47:169-76.
4. Eyer P. Neuropsychopathological changes by organophosphorus compounds - a review. Hum Exp Toxicol 1995;14:857-64.
5. Gerson S, Shaw FH. Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet 1961;1:1371-4.
6. Padilla S. The neurotoxicity of cholinesterase-inhibiting insecticides: Past and present evidence demonstrating persistent effect. Inhalation Toxicol 1995;7:903-10.
7. Rosenstock L, Keifer M, Daniel WE, McConnell R, Claypoole K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet 1991;338:223-7.
8. Savage EP, Keefe TJ, Mounce LM, Heaton RK, Lewis JA, Burcar PJ. Chronic neurological sequele of acute organophosphate pesticide poisoning. Arch Environ Health 1988;43:38-45.
9. Gralewicz S, Lutz P, Szymczak W. Hyposensitivity to amphetamine following exposure to chlorphenvinphos. Protection by amphetamine preexposure. Acta Neurobiol Exp 2000;60:203-7.
10. Lutz P, Tomas T, Gralewicz S, Nowakowska E. Long-term effects of acute exposure to chlorphenvinphos on behavioural responsiveness to amphetamine and scopolamine in rats. Int J Occup Med Environ Health 2000;13:215-22.
11. Gralewicz S, Soćko R. Persisting behavioural and electroencephalographic effects of exposure to chlorphenvinphos, an organophosphorous pesticide, in laboratory animals. Int J Occup Med Environ Health 1997;10:375-94.
12. Overstreet DH, Miller CS, Janowsky DS, Russel R.W. Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity. Toxicology 1996;111:119-34.
13. Gralewicz S. Behavioral sensitization to amphetamine induced by a single i.p. dose of oxotremorine in the rat. Acta Neurobiol Exp 2002;62:93-8.
14. Gralewicz S, Lutz P, Wiaderna D, Tomas T. Alteration in behavioral sensitivity to amphetamine after treatment with oxotremorine. Effect of dose and test environment. Behav Brain Res 2003;147:163-73.
15. Final report from the studies on the project "Persistent functional changes in the central nervous system after exposure to organophosphorous compounds, acetylcholinesterase inhibitors. An experimental study" supported by the Polish Committee for Scientific Research, Grant 4 P05D 038 18;2003 [unpublished].
16. Birrell CE, Balfour DJ. The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine. Psychopharmacology (Berl) 1998;37:1503-13.
17. Domino EF. Nicotine induced behavioral locomotor sensitization. Prog Neuropsychopharmacol Biol Psychiat 2001;25:59-71.
18. Shaw KP, Aracava Y, Akaike A, Rickett DL, Albuquerque EX. The reversible cholinesterase inhibitorphysostigmine has channel-blocking and agonist effect on the acetylcholine receptor-ion channel complex. Mol Pharmacol 1985;28:527-38.
19. Gralewicz S, Tomas T, Soćko R. Interaction of chlorphenvinphos with cholinergic receptors in the rabbit hypothalamus. Neurotoxicol Teratol 1995;17:289-95.
20. Winer BJ. Statistical Principles in Experimental Design. New York: McGraw Hill; 1962.
21. Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron 1998;21:467-76.
22. Yeomans JS. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacol 1995;12:3-16.
23. Mathur A, Shandarin A, La Violette SR, Parker J, Yeomans JS. Locomotion and stereotypy induced by scopolamine: contribution of muscarinic receptors near the pedunculopontine tegmental nucleus. Brain Res 1997;775:144-55.
24. Laviolette SR, Prieber RP, Yeomans JS. Role of laterodorsal tegmental nucleus in scopolamine- and amphetamine-induced locomotion and stereotypy. Pharmacol Biochem Behav 2000;65:163-74.
25. Vanderschuren LJNM, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacol 2000;151:99-120.
26. Zhou F-M, Liang Y, Dani JA. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nature Neurosci 2001;4/12:1224-9.
27. Schoffelmeer ANM, De Vries TJ, Wardeh G, van de Ven HWM, Vanderschuren LJMJ. Psychostimulant-induced behavioral sensitizaction depends on nicotinic receptor activation. J Neurosci 2002;22:3269-76.
28. Calogero AE, Gallucci WT, Bernardini R, Saoutis C, Gold PW, Chrousos GP. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinol 1988;47:303-8.
29. Matta SG, Fu Y, Valentine JD, Sharp BM. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinol 1998;23:103-13.
30. Steiner JA, Grahame-Smith DG. Central pharmacological control of corticosterone secretion in the intact rat. Demonstration of cholinergic and serotoninergic facilitatory and alpha-adrenergic inhibitory mechanisms. Psychopharmacol (Berl) 1980;71:213-7.
31. Marinelli M, Piazza PV. Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 2002;16:387-94.
32. Deroche V, Piazza PV, Casolini P, Maccari S, Le Moal M, Simon H. Stress-induced sensitization to amphetamine or morphine psychomotor effects depends on stress-induced corticosterone secretion. Brain Res 1992;598:343-8.
33. Deroche V, Marinelli M, Maccari S, LeMoal M, Simon H, Piazza PV. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J Neurosci 1995;15:7181-8.
34. Osicka-Koprowska A, Lipska M, Wysocka-Paruszewska B. Effects of chlorphenvinphos on plasma corticosterone and aldosterone levels in rats. Arch Toxicol 1984;55:68-9.
35. Lutz P, Gralewicz S, Kur B, Wiaderna D. Effects of single intraperitoneal exposure to chlorphenvinphos on behavioral responsiveness to amphetamine or scopolamine in rats. A comparative study. Int J Occup Med Environ Health [in press].
36. Pope CN, Chakraborti TK, Chapman ML, Farrar JD. Long-term neurochemical and behavioural effects induced by acute chlorpyrifos treatment. Pharmacol Biochem Behav 1992;42:251-4